Skip to main content.

Martha Rosenberg's Blog

Much direct-to-consumer drug advertising makes a mockery of the entire U.S. health care system by... more »
posted 03/15/18
Review: Mental Health, Inc. exposes how various entities - from indifferent professional... more »
posted 01/06/18
Gary Younge, a black reporter who grew up in England demonstrates in a moving new book, asks hard... more »
posted 06/10/17

Martha Rosenberg's Latest Comments

Posted by Martha Rosenberg | Saturday, 2016-03-12, 12:02
Anxiety and alcoholism are not "mental illnes." Whenever they are termed that way and there is...
Posted by Martha Rosenberg | Wednesday, 2015-09-30, 06:57
Like the removal of pink slime from school lunch programs and rBGH from almost all milk, consumer...
Posted by Martha Rosenberg | Friday, 2015-08-14, 10:31
When reporters expose drug company marketing that pretends to be grassroots, patients often write...

Martha Rosenberg's Work

According to whistleblowers who sold Xolair at Novartis and Genentech--a scheme of kickbacks and bribes, misinformation about Xolair’s approved uses and risks and insurance fraud was used to sell Xolair

After an 18 month investigation into the high cost of Gilead’s hepatitis C drug Sovaldi, the Senate Finance Committee said the prices did not reflect the cost of research and development and that Gilead cared about “revenue” not “affordability and accessibility.”

Drug companies have "bought" opioid favorable guidelines and the FDA continues to approve new opioids. Don't blame patients for the opioid abuse epidemic